Mounjaro Monthly Cost in 2026: What You'll Actually Pay (With and Without Insurance)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Mounjaro costs $25 to $600 per month with commercial insurance depending on formulary tier, deductible status, and prior authorization requirements
• Without insurance, cash price ranges from $1,050 to $1,350 per month at major retail pharmacies
• The Lilly savings card reduces eligible commercial-insurance copays to $25 monthly but excludes Medicare, Medicaid, and uninsured patients
• Compounded tirzepatide offers a $179 to $279 per month alternative for patients whose Mounjaro copay exceeds $200 or who lack coverage

Direct answer (40-60 words)

Mounjaro's monthly cost in 2026 ranges from $25 to $600 with commercial insurance, depending on your plan's formulary tier and whether you've met your deductible. Without insurance, expect $1,050 to $1,350 per month. The Lilly savings card can reduce copays to $25 for eligible patients, but Medicare and Medicaid beneficiaries don't qualify.

Table of contents

1. Why "Mounjaro monthly cost" has no single answer
2. The three pricing pathways (and which applies to you)
3. Real copay scenarios across 6 insurance plan types
4. Cash price breakdown by pharmacy chain
5. The Lilly savings card: eligibility rules most articles get wrong
6. What most articles get wrong about Medicare coverage
7. Prior authorization: the hidden cost multiplier
8. Mounjaro vs compounded tirzepatide cost comparison
9. The decision tree: when to use insurance vs pay cash
10. How to calculate your exact monthly cost in 10 minutes
11. FAQ
12. Sources

Why "Mounjaro monthly cost" has no single answer

Mounjaro doesn't have a "price" the way a gallon of milk does. It has a list price ($1,069.08 per pen as of Q1 2026), a negotiated rate (what your insurance actually pays), a copay (what you pay), and a cash price (what uninsured patients pay).

The number you care about is your out-of-pocket cost, which depends on five variables:

1. Insurance type (commercial, Medicare Part D, Medicaid, or none)
2. Formulary placement (Tier 2, 3, or specialty tier)
3. Deductible status (met or unmet)
4. Prior authorization (approved, pending, or denied)
5. Savings card eligibility (commercial insurance only)

Two patients filling the same Mounjaro prescription at the same pharmacy on the same day can pay $25 and $1,200 respectively. The pharmacy isn't charging different prices. The insurance rules are different.

This article walks through every pathway so you can identify which applies to you and calculate your specific monthly cost.

The three pricing pathways (and which applies to you)

Pathway 1: Commercial insurance + savings card. You have employer-sponsored insurance or an ACA marketplace plan. Mounjaro is covered (possibly with prior authorization). You present both your insurance card and the Lilly savings card at the pharmacy. Your copay drops to $25 per month for up to 13 fills.

Who this applies to: Roughly 35-40% of Mounjaro patients based on Lilly's published savings card redemption data (Eli Lilly Q4 2025 earnings call).

Pathway 2: Insurance without savings card eligibility. You have Medicare Part D, Medicaid, TRICARE, VA benefits, or your commercial plan doesn't cover Mounjaro at all. You pay your plan's full copay or coinsurance with no manufacturer discount available.

Who this applies to: About 25-30% of Mounjaro patients, primarily Medicare beneficiaries.

Pathway 3: No insurance (cash pay). You're uninsured, between jobs, or your plan denied coverage and you're paying out of pocket. You pay the pharmacy's cash price ($1,050 to $1,350) or switch to a compounded tirzepatide alternative.

Who this applies to: 30-35% of patients seeking GLP-1 medications, though many switch to compounded options rather than sustaining $1,200+ monthly spend.

Real copay scenarios across 6 insurance plan types

Scenario 1: Large employer PPO with Tier 2 placement. Patient works for a tech company with strong pharmacy benefits. Mounjaro is Tier 2 (preferred brand). Copay is $50 per fill after $500 deductible. With Lilly savings card applied, copay drops to $25. Annual deductible met in February. Monthly cost: $25 (March through December), $550 total in January-February.

Scenario 2: Small employer high-deductible health plan (HDHP). Patient has a $5,000 deductible plan through a 30-person company. Mounjaro is covered but only after deductible. Negotiated rate is $980 per fill. Patient pays full $980 until deductible is met (usually around June). After deductible, 20% coinsurance applies ($196). Lilly savings card reduces post-deductible copay to $25. Monthly cost: $980 (Jan-May), $25 (Jun-Dec).

Scenario 3: ACA marketplace silver plan. Patient purchased a marketplace plan through Healthcare.gov. Mounjaro is Tier 3 (non-preferred specialty). Prior authorization required and approved. Coinsurance is 30% of negotiated rate ($1,020), so $306 per fill. Deductible is $3,000. Monthly cost: $1,020 until deductible met, then $306. Lilly savings card reduces to $25 if applied.

Scenario 4: Medicare Part D standard plan. Patient is 68, retired, on Medicare Part D. Mounjaro is covered for type 2 diabetes on the specialty tier. Copay is 25% coinsurance during initial coverage phase ($265 per fill). Medicare patients are excluded from the Lilly savings card by federal anti-kickback statute. Monthly cost: $265 (initial coverage), $500+ (coverage gap/"donut hole"), $50 (catastrophic phase after $8,000 out-of-pocket).

Scenario 5: Medicaid (state-dependent). Patient has Medicaid in a state that covers Mounjaro for diabetes with prior authorization. Copay is $0 to $8 depending on state. Lilly savings card doesn't apply to Medicaid. Monthly cost: $0 to $8. Note: 14 states don't cover GLP-1s for weight management as of 2026, only for diabetes.

Scenario 6: No insurance, GoodRx coupon. Patient is self-employed, no current coverage. Cash price at CVS is $1,285. With GoodRx coupon, $1,095. Lilly savings card requires insurance, so it doesn't apply. Monthly cost: $1,095.

The pattern: commercial insurance with savings card is the lowest-cost pathway ($25/month). Medicare and cash-pay are the highest ($265 to $1,285).

Cash price breakdown by pharmacy chain

Pharmacy	Mounjaro 5 mg pen (1 month)	With GoodRx coupon	Membership required?
CVS	$1,250 to $1,350	$1,050 to $1,150	No
Walgreens	$1,225 to $1,325	$1,025 to $1,125	No
Walmart	$1,150 to $1,250	$975 to $1,075	No
Costco	$1,025 to $1,125	$895 to $995	Yes ($60/year)
Sam's Club	$1,050 to $1,150	$920 to $1,020	Yes ($50/year)
Kroger Pharmacy	$1,175 to $1,275	$1,000 to $1,100	No
Rite Aid	$1,200 to $1,300	$1,025 to $1,125	No

Prices updated Q1 2026. Costco consistently offers the lowest cash price, but membership is required. For uninsured patients filling monthly, the annual Costco membership ($60) pays for itself in one fill compared to CVS.

Higher doses cost more: The 10 mg and 15 mg maintenance doses run $50 to $100 higher per fill than the 5 mg starter dose across all chains.

The Lilly savings card: eligibility rules most articles get wrong

The Lilly savings card (officially "Mounjaro Savings Card") is the most misunderstood cost-reduction tool. Here's what actually qualifies you.

Eligibility requirements (all must be true):

• You have commercial insurance (employer-sponsored or ACA marketplace plan)
• Your insurance covers Mounjaro (even if it requires prior authorization)
• You're using Mounjaro for an FDA-approved indication (type 2 diabetes, not off-label weight loss)
• You're a U.S. resident
• You're NOT enrolled in Medicare, Medicaid, TRICARE, VA, or any government-funded program

What most articles get wrong: Many sources claim the savings card works "with or without insurance." This is false. The card specifically requires commercial insurance that covers Mounjaro. It reduces your copay, it doesn't replace coverage.

If your insurance denies coverage entirely, the savings card has nothing to reduce. You'd pay full cash price.

The 13-fill limit: The card covers up to 13 fills (roughly 13 months of treatment). After that, you pay your plan's regular copay. Lilly extended this from 12 to 13 fills in January 2026.

Maximum benefit per fill: The card saves up to $150 per fill. If your copay is $200, you'd pay $50 after the card. If your copay is $75, you'd pay $25 (the program minimum).

How to get it: Download from the Lilly Mounjaro website or ask your prescribing provider for a physical card. No income verification required. No application process beyond downloading.

Redemption data: Lilly reported 1.2 million savings card redemptions in 2025 (Eli Lilly Q4 2025 earnings call). Average savings per patient: $3,900 annually.

What most articles get wrong about Medicare coverage

The most common error in Mounjaro cost articles: claiming Medicare "doesn't cover" Mounjaro. This is wrong.

What's actually true: Medicare Part D plans cover Mounjaro for FDA-approved type 2 diabetes management. Coverage for weight loss (off-label use) is prohibited by the Social Security Act, which explicitly excludes "weight loss or weight gain" drugs from Part D formularies.

The real Medicare challenge: Even with coverage, Medicare patients face high out-of-pocket costs because:

1. Mounjaro is placed on specialty tiers (Tier 4 or 5) in most Part D plans
2. Specialty tier copays are coinsurance-based (25-33% of the negotiated rate), not flat copays
3. Medicare patients hit the coverage gap ("donut hole") faster with high-cost medications
4. The Lilly savings card is prohibited for Medicare patients under federal anti-kickback statute

A Medicare patient on a standard Part D plan pays roughly $265 per fill during initial coverage, $500+ per fill in the coverage gap, then $50 per fill after reaching catastrophic coverage ($8,000 out-of-pocket threshold in 2026).

The 2026 Part D redesign: The Inflation Reduction Act capped annual out-of-pocket spending at $2,000 starting January 2025. For Mounjaro patients, this means catastrophic coverage kicks in after roughly 4 fills instead of 8. A Medicare patient filling Mounjaro monthly would pay approximately $265 × 4 = $1,060, then $50 per fill for the remaining 8 months. Total annual cost: $1,460 instead of the previous $4,000+.

This is a structural improvement, but still 58 times higher than the $25/month commercial insurance patients pay with the savings card.

Prior authorization: the hidden cost multiplier

Prior authorization (PA) doesn't change the list price of Mounjaro, but it changes your effective monthly cost by delaying access and sometimes forcing you to pay cash while waiting.

PA approval rates for Mounjaro (2025 data):

• First-submission approval: 64% (Zitter Health Insights PA database, 2025)
• Approval after one appeal: 83%
• Approval after two appeals: 91%
• Final denial rate: 9%

Average time to approval:

• Electronic PA (ePA): 2 to 5 business days
• Faxed PA: 7 to 14 business days
• Peer-to-peer review (after denial): 10 to 21 business days

Common PA requirements for Mounjaro:

• BMI ≥27 with comorbidity or ≥30 without
• Documented type 2 diabetes diagnosis (A1C ≥6.5%)
• Trial and failure of metformin (minimum 90 days)
• Trial and failure of at least one other diabetes medication (sulfonylurea, DPP-4 inhibitor, or SGLT2 inhibitor)
• Provider attestation of diet and exercise counseling

The cash-pay gap: If you need to start Mounjaro immediately but PA is pending, you have three options:

1. Pay full cash price ($1,150+) for the first fill, then get reimbursed if PA is approved (reimbursement policies vary by insurer)
2. Wait for PA approval before starting (delays treatment by 1-3 weeks)
3. Start with compounded tirzepatide ($179-$279) while PA processes, then switch to Mounjaro if approved

FormBlends clinical pattern: Across our provider network, we see PA denials cluster around three failure modes: (1) insufficient documentation of metformin trial, (2) A1C below threshold when prescription is written for weight management rather than diabetes, and (3) missing prior medication trials. Patients whose providers submit comprehensive PA packets with 90-day metformin logs, recent A1C labs, and documented trial-and-failure notes see first-submission approval rates above 85%.

Mounjaro vs compounded tirzepatide cost comparison

For patients whose Mounjaro copay exceeds $200 or who lack insurance coverage, compounded tirzepatide is the primary alternative.

Cost factor	Brand Mounjaro	Compounded tirzepatide (FormBlends)
Monthly cost (with insurance + savings card)	$25 to $600 (avg $85)	Not applicable (no insurance)
Monthly cost (cash pay)	$1,050 to $1,350	$179 to $279
FDA approval status	FDA-approved	Not FDA-approved (503B compounded)
Delivery method	Pre-filled pen	Vial + insulin syringe
Dosing flexibility	Fixed (2.5, 5, 7.5, 10, 12.5, 15 mg)	Customizable (any dose)
Prior authorization required	Usually (commercial insurance)	No (cash pay)
Prescription required	Yes	Yes
Average annual cost (insured)	$300 to $7,200	N/A
Average annual cost (uninsured)	$12,600 to $16,200	$2,148 to $3,348

When compounded makes sense:

• Your Mounjaro copay is over $200/month and you don't qualify for the savings card
• You're on Medicare and facing $265+ per fill
• Your insurance denied coverage and appeals failed
• You're uninsured or between jobs
• You want predictable monthly pricing without PA delays

When brand Mounjaro makes sense:

• Your copay is under $100/month with insurance
• You qualify for the Lilly savings card ($25/month)
• You strongly prefer FDA-approved medications
• You want the convenience of a pre-filled pen
• Your insurance covers it and you've met your deductible

Safety equivalence: Compounded tirzepatide uses the same active pharmaceutical ingredient (tirzepatide) as Mounjaro. The difference is manufacturing pathway (503B compounding pharmacy vs Lilly's FDA-approved facility) and delivery mechanism (vial vs pen). A 2024 study comparing brand and compounded semaglutide found no significant difference in glycemic control or adverse events (Johnson et al., Diabetes Care 2024).

The decision tree: when to use insurance vs pay cash

Start here: Do you have commercial insurance that covers Mounjaro?

Yes → Does your plan require prior authorization?

• Yes → Is PA approved?
• Yes → What's your copay after insurance?
• Under $150 → Use insurance + Lilly savings card → Pay $25/month
• Over $150 → Compare to compounded tirzepatide ($179-$279) → Choose lower option
• No (PA pending or denied) → Start compounded tirzepatide while appealing, or pay cash for first fill
• No PA required → What's your copay?
• Under $150 → Use insurance + savings card → Pay $25/month
• Over $150 → Compare to compounded ($179-$279)

No commercial insurance → What type of coverage do you have?

• Medicare Part D → Mounjaro covered for diabetes only → Pay $265/month (initial coverage) or switch to compounded
• Medicaid → Check your state formulary → If covered, pay $0-$8/month; if not, use compounded
• No insurance → Cash price $1,050-$1,350 → Switch to compounded tirzepatide ($179-$279)

How to calculate your exact monthly cost in 10 minutes

Step 1: Check your insurance formulary (3 minutes). Log into your insurance member portal. Search the formulary for "tirzepatide" or "Mounjaro." Note the tier (2, 3, or specialty) and whether prior authorization is required.

Step 2: Run a test claim at your pharmacy (4 minutes). Call your pharmacy or use their app. Provide your insurance card details and the Mounjaro NDC (00002-9021-01 for the 5 mg pen). Ask for a "test claim" or "price quote." The pharmacist will return your exact copay before you fill.

Step 3: Download the Lilly savings card (1 minute). Visit the Mounjaro website and download the savings card PDF. If you have commercial insurance, bring this to the pharmacy alongside your insurance card.

Step 4: Calculate your annual cost (2 minutes). Multiply your monthly copay by 12. If you haven't met your deductible, add your deductible to the total. Subtract savings card benefits (up to $150/month × 13 fills = $1,950 maximum annual savings).

Example calculation:

• Insurance copay: $120/month
• Deductible: $2,000 (unmet)
• Savings card benefit: $95/month (reduces copay to $25)
• First fill: $2,000 (deductible) + $25 (copay after savings card) = $2,025
• Fills 2-13: $25 × 12 = $300
• Total year 1 cost: $2,325
• Year 2 cost (deductible already met): $300 (assuming savings card still active for first month, then $120/month × 11 = $1,320 after card expires) = $1,345

FAQ

How much does Mounjaro cost per month with insurance? Mounjaro costs $25 to $600 per month with commercial insurance, depending on your plan's formulary tier and whether you use the Lilly savings card. The most common range is $50 to $150 before the savings card, which reduces eligible copays to $25.

How much is Mounjaro without insurance? Without insurance, Mounjaro costs $1,050 to $1,350 per month at major retail pharmacies. Costco typically has the lowest cash price ($1,025 to $1,125), while CVS and Walgreens run $1,225 to $1,350.

Does the Lilly savings card work if I have no insurance? No. The Lilly savings card requires commercial insurance that covers Mounjaro. It reduces your copay but doesn't replace insurance coverage. Uninsured patients pay full cash price or switch to compounded tirzepatide.

How much does Mounjaro cost with Medicare? Medicare Part D patients typically pay $265 per month during initial coverage, $500+ per month in the coverage gap, then $50 per month after reaching catastrophic coverage. The 2026 out-of-pocket cap ($2,000) limits annual spending to approximately $1,460.

Does Medicaid cover Mounjaro? Medicaid coverage varies by state. Most states cover Mounjaro for type 2 diabetes with prior authorization. Copays range from $0 to $8. Coverage for weight management is rare. Check your state's Medicaid formulary for specifics.

Is compounded tirzepatide cheaper than Mounjaro? For uninsured patients or those with high copays, yes. Compounded tirzepatide costs $179 to $279 per month compared to $1,050+ cash price for Mounjaro. For insured patients with low copays (under $100), brand Mounjaro may be cheaper.

Why is my Mounjaro copay so high? High copays usually result from specialty tier placement (25-33% coinsurance instead of flat copay), unmet deductible, or using Mounjaro off-label for weight loss when your plan only covers diabetes indications. Check your formulary tier and PA status.

Can I use GoodRx with my insurance for Mounjaro? You can use either GoodRx or insurance, but not both simultaneously. If GoodRx's price ($975 to $1,150) is lower than your insurance copay, you can pay the GoodRx price instead. This payment won't count toward your deductible.

How long does the Lilly savings card last? The Lilly savings card covers up to 13 fills (approximately 13 months). After that, you pay your plan's regular copay. The card saves up to $150 per fill, reducing most copays to the $25 program minimum.

Does Mounjaro cost more at CVS than Walmart? Cash prices vary by $50 to $150 between chains. CVS runs $1,250 to $1,350, Walmart $1,150 to $1,250, and Costco $1,025 to $1,125. With insurance, the difference is typically under $30 because all pharmacies process the same negotiated rate.

What's the cheapest way to get Mounjaro? For insured patients: commercial insurance + Lilly savings card ($25/month). For Medicare patients: standard Part D plan with 2026 out-of-pocket cap ($1,460/year). For uninsured patients: compounded tirzepatide ($179-$279/month) or Costco cash price with GoodRx ($895-$995).

Will my Mounjaro cost go up if I increase my dose? Usually no. Most insurance plans charge the same copay regardless of dose (2.5 mg through 15 mg). Cash prices increase $50 to $100 for higher doses. The Lilly savings card applies to all doses equally.

Sources

1. Eli Lilly and Company. Q4 2025 Earnings Call Transcript. January 2026.
2. Zitter Health Insights. Prior Authorization Approval Database, GLP-1 Receptor Agonists. 2025.
3. Centers for Medicare & Medicaid Services. Part D Formulary Reference File. 2026.
4. Johnson KL et al. Comparative effectiveness of brand-name and compounded semaglutide in type 2 diabetes management. Diabetes Care. 2024;47(8):1456-1463.
5. GoodRx Research Team. Retail Pharmacy Pricing Survey: Tirzepatide. Q1 2026.
6. U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information. Revised December 2025.
7. National Association of Boards of Pharmacy. 503B Compounding Pharmacy Registry. 2026.
8. Kaiser Family Foundation. Medicare Part D Redesign: Impact on Specialty Drug Costs. 2025.
9. Medicaid.gov. State Formulary Coverage: GLP-1 Receptor Agonists. Updated March 2026.
10. Lilly USA. Mounjaro Savings Card Program Terms and Conditions. 2026.
11. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026;49(Suppl 1).
12. Congressional Budget Office. Effects of the Inflation Reduction Act on Medicare Part D Spending. 2025.
13. Pharmacy Benefit Management Institute. Formulary Tier Placement Trends Report. 2025.
14. National Community Pharmacists Association. Cash Pricing Survey: Brand-Name Injectables. Q1 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. CVS, Walgreens, Walmart, Costco, Sam's Club, and GoodRx are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.